Detalles de la búsqueda
1.
Pasireotide treatment does not modify hyperglycemic and corticosterone acute restraint stress responses in rats.
Stress
; 21(4): 370-375, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29661114
2.
Radiotherapy and pasireotide treatment of a growth hormone producing pituitary tumor in a diabetic dog.
Can Vet J
; 59(10): 1089-1093, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30510314
3.
Somatostatin receptor activation is involved in the control of daily torpor in a seasonal mammal.
Am J Physiol Regul Integr Comp Physiol
; 309(6): R668-74, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26157058
4.
Osilodrostat (LCI699), a potent 11ß-hydroxylase inhibitor, administered in combination with the multireceptor-targeted somatostatin analog pasireotide: A 13-week study in rats.
Toxicol Appl Pharmacol
; 286(3): 224-33, 2015 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25981165
5.
Lung volume quantified by MRI reflects extracellular-matrix deposition and altered pulmonary function in bleomycin models of fibrosis: effects of SOM230.
Am J Physiol Lung Cell Mol Physiol
; 306(12): L1064-77, 2014 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24727584
6.
SOM230: a new therapeutic modality for Cushing's disease.
Chimia (Aarau)
; 68(7-8): 483-4, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25437387
7.
Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors.
Neuroendocrinology
; 95(3): 232-47, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22156600
8.
Combination of pasireotide and octreotide: effects on GH and IGF-I secretion and glucose metabolism in healthy volunteers.
Endocrine
; 75(2): 537-548, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34741720
9.
Somatostatin analogue pasireotide (SOM230) inhibits catecholamine secretion in human pheochromocytoma cells.
Cancer Lett
; 524: 232-244, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34637845
10.
Effect of SOM230 (pasireotide) on corticotropic cells: action in dogs with Cushing's disease.
Neuroendocrinology
; 94(2): 124-36, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21525729
11.
Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.
Future Oncol
; 7(7): 895-913, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21732759
12.
Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages.
Cell Mol Gastroenterol Hepatol
; 11(5): 1405-1436, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33482394
13.
Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro.
J Clin Endocrinol Metab
; 94(2): 654-61, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19001514
14.
The somatostatin analog SOM230 (pasireotide) ameliorates injury of the intestinal mucosa and increases survival after total-body irradiation by inhibiting exocrine pancreatic secretion.
Radiat Res
; 171(6): 698-707, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19580476
15.
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas.
Clin Cancer Res
; 13(9): 2738-44, 2007 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17473207
16.
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion.
Endocr Relat Cancer
; 14(1): 91-102, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17395978
17.
SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3?
Mol Endocrinol
; 20(2): 426-36, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16223973
18.
Ectopic expression of Pax4 in pancreatic δ cells results in ß-like cell neogenesis.
J Cell Biol
; 216(12): 4299-4311, 2017 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29025873
19.
Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1-Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression.
Endocrinology
; 157(5): 1789-98, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26990064
20.
Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly.
Endocrine
; 53(1): 210-9, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26906713